Mobile

A phase 2, multicenter, open-label, single arm, two-stage study to evaluate the efficacy and safety of CC-4047 (Pomalidomide) in patients with advanced soft tissue sarcomas who have relapsed or are re...

Update Il y a 4 ans
Reference: EUCTR2007-005670-31

A phase 2, multicenter, open-label, single arm, two-stage study to evaluate the efficacy and safety of CC-4047 (Pomalidomide) in patients with advanced soft tissue sarcomas who have relapsed or are refractory to systemic anticancer therapy

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the efficacy of CC-4047

Inclusion criteria

  • Locally recurrent, unresectable or metastatic soft tissue sarcomas relapsed or refractory to doxorubicin and ifosfamide chemotherapy

Links